非小细胞肺癌表皮生长因子受体酪氨酸激酶抑制剂耐药机制(4)
[6] Greulich， H.， et al.， Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med， 2005. 2(11)： p. e313.[7] Linardou， H.， et al.， Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents： a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. Lancet Oncol ......
您现在查看是摘要页，全文长 2557 字符。